12:00 AM
Oct 22, 2012
 |  BC Week In Review  |  Company News  |  Deals

Benitec, Tacere deal

Benitec will acquire RNAi company Tacere for about 102.3 million newly issued ordinary shares, which the companies valued at about $1.5 million. The shares represent a 9.5% stake in Benitec. In 2006, Tacere received an exclusive license from Benitec to...

Read the full 180 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >